Panbela Therapeutics Inc. (PBLA) Misses Q2 EPS by 147c

Panbela Therapeutics Inc. (OTC: PBLA) reported Q2 EPS of ($1.47).

For earnings history and earnings-related data on Panbela Therapeutics Inc. (PBLA) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• KeyBanc on Terreno Realty Corp (TRNO): 'Acquisition Engine Turning Higher; Infill Strategy Delivering'
• Canaf Reports Financial Results for Q2 2026 and Progress on Self-Storage Platform